Table 1.
Eligibility criteria pertaining to the population & clinical areas, interventions, comparators, attributes of CPGs and recommendation characteristics (PICAR) statement.
Table 2.
Standardized levels of evidence used to inform recommendations reported by CPGs.
Fig 1.
A flow chart summarizing the results of the literature screening and selection process.
Fig 2.
Median AGREE II domain Scores and associated ranges for all included guidelines.
The horizontal line at 60% represents the cut-off score at or above which each domain was considered ‘adequately addressed’.
Table 3.
Summary of recommendations for the treatment of VTE with LMWH and FDP for five outpatient indications.
Table 4.
Summary of recommendations related to the prevention of VTE with LMWH and FDP for four outpatient indications.
Table 5.
Number of clinical practice guidelines reporting recommendations by quality type recommendations reported by indication.